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Abstract
Jo Lynn Jeter is a 2004 graduate of the University of Oklahoma College of Law. She wrote this
eBrief while working on the Project on Intellectual Property Rights in Living Matter under the
direction of Professor Drew Kershen. Below, Ms. Jeter discusses the three types of patent and
patent-like protection available in the United States for living material: utility patents, Plant
Variety Protection Act (PVPA) certificates, and plant patents. A utility patent, as would be
obtained for an ordinary invention, provides the greatest protection but is typically more difficult
and expensive to obtain. The plant patent and PVPA certificate provide attractive alternatives to
inventors and breeders. Plant patents are designed to protect asexually-reproduced plants.
PVPA certificates are not patents at all, and are administered by the U.S. Department of
Agriculture to protect sexually-reproduced plants.
Edited by Matthew B. Sellers
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I.

Introduction

Throughout the development of patent law in the United States, one principle has
remained constant: discoveries in nature are not patentable, only inventions are patentable.1
However, the question of whether man-made plants, animals or microorganisms are discoveries
in nature or inventions has been the subject of considerable controversy. This eBrief discusses
such alternating ideology through statutory development and interpretation.
II.

History and Background

The U.S. Constitution authorizes Congress “to promote the Progress of Science and
useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their

1

See Funk Bros. Seed Co. v. Kalo Inoculant Co., 333 U.S. 127, 131 (1948) (holding that the discovery that certain
bacteria strains of species can be mixed without harmful effect to the properties of either is not patentable because
their qualities were the work of nature). The Court also held that patents cannot issue for the discovery of the
phenomena of nature. A product must be more than new and useful to be patentable; it must also satisfy the
requirements of invention or discovery. Id.; see Gottschalk v. Benson, 409 U.S. 63, 67 (1972); Diamond v.
Chakrabarty, 447 U.S. 303, 309 (1980). See generally Graham v. John Deere Co., 383 U.S. 1 (1966). For further
discussion about the requirement that an “invention” be an actual invention rather than a “discovery in nature,” see
Jo Lynn Jeter, Agricultural Biotechnology: United States Case Law, 2 OKLA. J.L. & TECH. 15 (2004)
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respective Writings and Discoveries…” 2

Congress’ first legislation implementing the

Constitutional provision came during the First Congress, when it enacted the Patent Act of
1790. 3

This law formed the basis for patents within the United States, creating general

requirements of novelty, utility, non-obviousness, and enablement/description. 4
Before 1930, the federal government denied patent protection for plants and animals. 5
Plants, even those created by man, were considered “products of nature” and were therefore not
subject to patent protection 6 . Even where a biological invention did not constitute a “product of
nature,” the claim typically could not sufficiently describe the invention in accordance with the
written description requirement. 7
In 1930, Congress enacted the Plant Patent Act (“PPA”), which only applied to certain
asexually reproduced plants.

8

This signaled as a significant departure from the longstanding

doctrine that plants were not a proper subject matter for patent protection and was the first
instance of a country awarding patents for living matter aside from yeast. 9 The PPA afforded the
agricultural industry the opportunity to participate in the benefits of the patent system, which had

2

U.S. CONST. art. I, § 8, cl. 8.
See S. REP. NO. 1979-82, at 2396 (1952).
4
See 35 U.S.C. § 101 (2000) (novelty and utility requirements: “any new and useful process, machine, manufacture
or composition of matter, or . . . improvement thereof”); id. § 103 (non-obviousness requirements: “[T]he
differences between the subject matter sought to be patented and the prior art are such that the subject matter as a
whole would (not) have been obvious . . . .”); id. § 112 (enablement/description requirement: “The specification
shall contain a written description of the invention, and of the manner and process of making and using it, in such
full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is
most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of
carrying out his invention.”); see also Graham, 383 U.S. at 1.
5
See Ex parte Latimer, 1889 Dec. Comm’r Pat. 123 (1889).
6
Id.
7
See 35 U.S.C. § 112 (2000) (“The specification shall contain a written description of the invention, and of the
manner and process of making and using it, in such full, clear, concise and exact terms as to enable any person
skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall
set forth the best mode contemplated by the inventor of carrying out his invention.”).
8
Id. §§ 161-164.
9
In 1873, the Patent Office granted Louis Pasteur a patent on “yeast, free form organic germs of disease, as an
article of manufacture.”
3
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previously only been enjoyed in the industrial field. By 1970 it became evident to Congress that,
due to biological advances, true-to-type reproduction was possible for sexually reproduced plants
(plants derived from a seed). Accordingly, Congress passed the Plant Variety Protection Act
(“PVPA”). 10 The PVPA was enacted to provide patent-like protection to sexually reproduced
plants. 11
Finally, in 1980, the U.S. Supreme Court ruled that the Patent Act of 1952 does
include some living organisms within the scope of its patentable subject matter, 12 despite
decisions of the Patent Board to the contrary. 13 This decision was made more precise in a 2001
U.S. Supreme Court holding that in enacting the PPA and the PVPA, Congress neither expressly
nor implicitly removed plants from generally patentable subject-matter. 14 Similarly, Congress
did not repeal general patent requirements by passing the more specific Plant Acts because there
is no irreconcilable conflict between the statutes. 15
Thus, one wishing to patent living matter in the United States today may have up
to three choices of applicable law, each of which contain different requirements and entitlements.
These Federal Statutes include the Plant Patent Act, the Plant Variety Protection Act, and the
Patent Act of 1952.

10

7 U.S.C. §§ 2321-2582 (2000).
The purpose of the act is “[t]o encourage the development of novel varieties of sexually reproduced plants and to
make them available to the public, providing protection available to those who breed, develop, or discover them, and
thereby promoting progress in agriculture in the public interest.” Plant Variety Protection Act, Pub. L. No. 91-577,
84 Stat. 1542 (1970).
12
See Diamond v. Chakrabarty, 447 U.S. 303 (1980).
13
See In re Merat, 519 F.2d 1390 (Cust. & Pat. App. 1975); In re Bergy, 596 F.2d 952 (Cust. & Pat. App. 1979).
14
J.E.M. AG Supply, Inc. v. Pioneer Hi-Bred Int’l, Inc. 534 U.S. 124, 145-46 (2001).
15
Id.
11

3

2 OKLA. J. L. & TECH. 24 (2004)
www.okjolt.org
III.
A.

United States Statutory Law

Plant Patent Act of 1930
The Plant Patent Act of 1930 (“PPA”) is a sub-chapter of the general Patent Act and, in

relevant part, provides that:
Whoever invents or discovers and asexually reproduces any distinct and new variety of
plant, including cultivated sports, mutants, hybrids, and newly found seedlings, other than
a tuber propagated plant or a plant found in an uncultivated state, may obtain a patent
therefor, subject to the conditions and requirements of this title. No plant patent shall be
declared invalid for noncompliance with section 112 of this title if the description is as
complete as is reasonably possible. In the case of a plant patent the grant shall be of the
right to exclude others from asexually reproducing the plant or selling or using the plant
so reproduced. 16
The conditions for obtaining a patent under the PPA are considerably different than those
under general patent law. For example, the PPA requires the plant variety be distinct 17 , rather
than useful 18 as required for a general utility patent. Distinct characteristics may include: habit;
immunity from disease; soil conditions; color of flower, leaf, fruit or stems; flavor; productivity;
storage qualities; perfume; form; ease of asexual reproduction; and defectiveness. 19

It is

immaterial whether the characteristics are inferior or superior to those of the existing varieties. 20
Furthermore, the written description requirements of general patent law are less stringent
in the PPA, requiring only a description “as complete as is reasonably possible.” 21 The U.S.
Court of Customs and Patent Appeals has interpreted this provision to mean that there is no

16

35 U.S.C. §§ 161-163 (2000).
Id. § 161.
18
Id. § 101.
19
See S. REP. NO. 315-71 (1930); see also Pan-Am. Plant Co. v. Matsui, 433 F. Supp. 693, 696-97 (N.D. Cal. 1977).
A plant variety is substantially different, and hence does not infringe an existing plant patent, where the new plant
has the ability to asexually reproduce with a far smaller percentage of culls than the existing plant. The lack of
defectiveness formed a significantly different characteristic that made it a different variety, despite the appearance
that the plants seemed to be of the same variety. Id.
20
See S. REP. NO. 315-71 (1930).
21
35 U.S.C. § 162 (2000).
17

4

2 OKLA. J. L. & TECH. 24 (2004)
www.okjolt.org
enablement requirement in a plant patent application.22 This is due to the impossibility of
producing the patented plant from a description, because it must be asexually reproduced.23
Nevertheless, the applicant ultimately bears the burden of clearly and precisely describing those
characteristics which define the new variety. 24
Both the PPA and the Patent Act include novelty and non-obviousness requirements.
“Novelty” refers to newness in its conception. 25 “Non-obviousness” requires that there be actual
inventiveness at the time the invention was made. 26
The limited scope of the PPA, applying only to asexually reproduced plants, ensures that
plant breeders reproduce their plants identically in every respect to the parent plant. Plant
patents under the Act cover only a single plant and its asexually reproduced progeny. 27
Propagation by asexual reproduction may be obtained through grafting, budding, cuttings,
layering, and division, for example, but not by seeds. 28
In applying the PPA, as in applying the Patents Act, there is a presumption of
patent validity that the challenger has the burden to overcome. 29 This presumption must be
overcome by sufficient evidence to invalidate an existing patent. 30 If the patent is valid, a plant

22

In re Greer, 484 F.2d 488, 490-91 (Cust. & Pat. App. 1973).
See Ex parte Solomons, 201 U.S.P.Q. (BNA) 42 (Bd. Pat. App. & Interf. 1978).
24
In re Greer, 484 F.2d at 491.
25
Yoder Bros., Inc. v. Cal.-Fla. Plant Corp., 537 F.2d 1347, 1377 (5th Cir. 1976).
26
35 U.S.C. § 103 (2000) (“A patent may not be obtained…if the differences between the subject matter sought to
be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the
invention was made to a person having ordinary skill in the art to which such subject matter pertains.”).
27
Imazio Nursery, Inc. v. Dania Greenhouses, 69 F.3d 1560, 1566-70 (Fed. Cir. 1995). As a result of the Plant
Patent Act’s asexual reproduction requirement, only a single plant, i.e., reproduction from one original specimen, is
protected by the plant patent. A defense to plant patent infringement is showing that the alleged infringing plant is
not an asexual reproduction of the patented plant. Part of this proof could be that defendant independently
developed the allegedly infringing plant. Infringement is not shown by proof of a plant having the same essential
characteristics as the patented plant. Id.
28
In re Arzberger, 112 F.2d 834, 836 (Cust. & Pat. App. 1940).
29
35 U.S.C. § 282 (2000).
30
Id.
23
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patentee has the “right to exclude others from asexually reproducing the plant or selling or using
the plant so reproduced.” 31
B.

Plant Variety Protection Act
The Plant Variety Protection Act (“PVPA”) is administered by the United States

Department of Agriculture, rather than the United States Patent Office. The PVPA provides in
relevant part that:
The breeder of any sexually reproduced or tuber propagated plant variety (other than
fungi or bacteria) who has so reproduced the variety… shall be entitled to plant variety
protection for the variety, subject to the conditions and requirements of this chapter, if the
variety is: (1) new, in the sense that… propagated or harvested material of the variety has
not been sold or otherwise disposed of to other persons…; (2) distinct, in the sense that
the variety is clearly distinguishable from any other variety the existence of which is
publicly known or a matter of common knowledge at the time of the filing of the
application; (3) uniform, in the sense that any variations are describable, predictable, and
commercially acceptable; and (4) stable, in the sense that the variety, when reproduced,
will remain unchanged with regard to the essential and distinctive characteristics of the
variety with a reasonable degree of reliability commensurate with that of varieties of the
same category in which the same breeding method is employed. 32
The PVPA and the PPA differ significantly in their purposes and the scope and nature of
their protection. The PPA grants a plant patent to one who “invents or discovers and asexually
reproduces any distinct and new variety of plant.” 33 The PVPA, however, entitles one to plant
variety protection if he has sexually reproduced the variety and otherwise met the requirements
of the Act. 34 As a result, protection under the PVPA extends to the entire plant variety, while the
PPA only protects that specific plant and its progeny. 35

31

Id.. § 163.
7 U.S.C. § 2402 (2000).
33
35 U.S.C. § 161 (2000).
34
7 U.S.C. § 2402 (2000).
35
Imazio Nursery, Inc. v. Dania Greenhouses, 69 F.3d 1560, 1566-70 (Fed. Cir. 1995); see discussion supra note 21.
32
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To qualify for a PVPA certificate, the variety must be new, distinct, uniform and stable. 36
These requirements are significantly less strict than those of the general patent law. Uniformity
under the PVPA requires that the variety be “describable, predictable and commercially
acceptable,” 37 and stability requires the variety “remain unchanged with regard to the essential
and distinctive characteristics of the variety” upon reproduction. 38 These requirements reduce
the precise written description and enablement requirements.
One wishing to patent a sexually reproduced plant variety must acquire a certificate of
protection from the Plant Variety Protection Office.39 This certificate confers on the owner the
exclusive right “to exclude others from selling the variety, or offering it for sale, or reproducing
it, or importing it, or exporting it, or using it in producing a hybrid or different variety” to the
extent provided by the PVPA. 40 The certificate is good for twenty years. 41
The PVPA contains three major exemptions from infringement, reducing the protection
of its patents as compared to those covered under the Patent Act. First, the PVPA allows for a
Public Interest Exemption, providing that “the Secretary may declare a protected variety open to
use…in order to insure an adequate supply of fiber, food or feed in this country and that the
owner is unwilling or unable to supply the public needs for the variety at a price which may
reasonably be deemed fair.” 42 Thus, the exemption authorizes compulsory licensing upon the
determination of public need. A second exemption to the PVPA is the Research Exemption,
which allows for the use and reproduction of a protected variety for plant breeding or other bona

36

7 U.S.C. § 2402(a)(1)-(4) (2000).
Id. § 2402(a)(3).
38
Id. § 2402(a)(4).
39
Id. § 2402.
40
Id. § 2483(a)(1).
41
Id. § 2483(b)(1). The 1994 Amendments, Pub. L. No. 103-349, substituted “20” years for “18” years.
42
7 U.S.C. § 2404 (2000).
37
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fide research. 43 The third exemption is the Farmer’s Exemption. This exemption allows a farmer
to use seed produced from a patented plant for production on his or her farm. 44 The farmer may
also sell the seed, so long as it is not for reproductive purposes. 45 The Farmer’s Exemption was
significantly diluted when Congress amended the PVPA in 1994. Congress struck the provision
which allowed a farmer to sell seed for reproductive purposes to other farmers. Prior to 1994,
the Farmer Exemption was given much attention and was interpreted to allow farmers to sell
seeds directly to other farmers, so long as they only kept and sold enough to replant their own
acreage. 46
In addition to substantially weakening the farmer’s exemption, Congress’ 1994
amendments considerably changed other aspects of the PVPA. For example, Congress inserted
the provision including tuber-propagated plants, such as potatoes, within the scope of the
PVPA. 47 This provision was the first form of intellectual property protection in the United States
for tuber-propagated plants. Congress also adopted a “Rule of Construction” stating that the
“sale or disposition of hybrid seed shall be considered to be a sale of harvested material of the
varieties from which the hybrid was produced.” 48 Thus, the PVPA was altered to protect firstgeneration hybrids.

The amendments granted PVPA certificate holders protection for all

“essentially derived” varieties, in addition to their “initial” varieties. 49 An “essentially derived
variety” is defined as “a variety that is predominantly derived from another variety or from a

43

Id. § 2544.
Id. § 2543.
45
Id.
46
See Delta & Pine Land Co. v. Peoples Gin Co., 694 F.2d 1012, 1017 (5th Cir. 1983) (holding the farmer’s
exemption is for direct sales between farmers, without the active participation of third parties. Third parties cannot
serve as a broker (create the sale), but can have an indirect role); Asgrow Seed Co. v. Winterboer, 513 U.S. 179,
794-95 (1995) (holding that under the farmer’s exemption, farmers can only keep for sale the amount of seed that
they need to plant their own acreage).
47
7 U.S.C. § 2402 (2000).
48
Id. § 2401(b)(3).
49
Id. § 2541(c).
44
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variety that is predominantly derived from the initial variety, while retaining the expression of
the essential characteristics that result from the genotype or combination of genotypes of the
initial variety.” 50 Other provisions were inserted that barred the right to protect public or known
varieties, varieties for which there was a filing of an application in another country more than
one year before the date of filing in the United States, and of varieties for which another person
was entitled to an earlier date of determination. 51
Congress described the 1994 amendments to the PVPA as an attempt to make the Act
consistent with the International Convention for the Protection of New Varieties of Plants
(“UPOV”) of March 1991. 52 The United States became a member of the UPOV in 1981 in order
to afford U.S. plant breeders protection in other countries. 53 The UPOV “provides for uniform
practices in the construction and administration of plant variety protection laws in the various
member states.” 54
Once a patent certificate is granted pursuant to the PVPA, the patent is presumed valid.
Infringement may occur if, during the years of protection, one without authority performs any of
the following acts regarding the protected variety: sells or markets the variety, imports or exports
the variety, sexually multiplies the variety for growing purposes, uses the variety in producing a
hybrid or different variety therefrom, or dispenses the variety to another without notice that it is

50

Id. § 2401(a)(3).
Id. § 2402(a), (b). “Date of determination” refers to the date in which an applicant who has filed for a PVPA
certificate has met all the requirements of the PVPA. Thus, § 2402 (b)(1) states that “if two or more applicants
submit applications on the same effective filing date for varieties that cannot be clearly distinguished from one
another, but that fulfills all other requirements of subsection (a) of this section, the applicant who first complies with
all requirements of this chapter shall be entitled to a certificate of plant variety protection, to the exclusion of any
other applicant.”
52
H.R. 699, 103d Cong. 2423 (1994).
53
Id. at 2425.
54
Id.
51
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protected. 55 The foregoing is not an exhaustive list of possible acts of infringement, but it
provides a basis for understanding the protection granted under the PVPA.
Generally, one charged with violating another’s rights under the PVPA will claim one or
more of three common defenses to patent infringement: invalid patent, non-infringement, or
authorized infringement. 56 Should a court find infringement pursuant to the PVPA, the remedies
available to the patent owner are more limited than under the general patent law. For example,
the Act provides courts the authority to grant an injunction to prevent the violation of any rights
under the PVPA, rather than damages. 57 Moreover, there is a limit to the amount of damages
awarded for infringement of a PVPA patent. 58 For example, the Act supplies the court with
guidelines directing the amount of damages that may be awarded with regard to particular
situations. 59 Courts may refuse to award damages when a patent owner cannot establish that the
alleged infringer knew, or should have known, that the variety was covered by the PVPA and no
relevant exemptions applied. 60
Protection under a patent certificate extends only to the owner of the patent or to an
assignee of the patent who has been assigned the entire bundle of common-law rights. 61 Any
transfer of less than all of the common-law rights is a “license” and such an arrangement does
not entitle the licensee the right to sue for patent infringement. 62 The right to sue is based on title

55

7 U.S.C. § 2541(a) (2000).
See id. § 2541(b)(1) (stating “Subject to paragraph (2), the owner of a protected variety may authorize the use of
the variety under this section subject to conditions and limitations specified by the owner”).
57
Id. § 2563.
58
Id. § 2567.
59
See id. § 2564.
60
See id. § 2564(d); see also Delta & Pine Land Co. v. Sinkers Corp., 197 F. Supp. 2d 1184, 1192 (E.D. Mo. 2001)
(finding that the alleged infringer must have known, or should have known, that the variety was protected by
PVPA).
61
Public Varieties of Miss., Inc. v. Sun Valley Seed Co. Inc., 734 F. Supp. 250, 252 (N.D. Miss. 1990).
62
Id.
56
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of the patent certificate. A licensee’s only remedy is suit against the patent holder for breach of
contract.
C.

Patent Act of 1952
The Patent Act of 1952 forms the foundation for all patent protection in the United States.

General utility patents have provided protection for inventions outside the agricultural sector for
many years while the U.S. Patent and Trademark Office (“USPTO”) refused to apply the general
Patent Act to living things, concluding they were discoveries in nature rather than inventions. 63
Finally, in 1980, the U.S. Supreme Court, in the landmark case of Diamond v. Chakrabarty,
found that Congress intended the patentable statutory subject matter to include “anything under
the sun that is made by man.” 64 Thus, interpretation of the Act finally concluded that general
utility patents may serve as intellectual property protection for plant and animal genetics. 65
The Patent Act of 1952 conveys patent protection to “whoever invents or discovers any
new and useful process, machine, manufacture or composition of matter, or any new and useful
improvement thereof.” 66

The U.S. Supreme Court, after examining the text and legislative

history of the Patent Act, gave the terms “manufacture” and “composition of matter” a broad
interpretation to include a live, human-made microorganism. 67

The Court reiterated that

discoveries in nature are not patentable, but stated that a non-naturally occurring manufacture or
63

See In re Merat, 519 F.2d 1390 (Cust. & Pat. App. 1975) (appellants sought patents for the process of breeding a
strain of dwarf hens with normal cocks, and for the product of the resulting dwarf chickens). The examiner rejected
the patents on the theory that a method of breeding animals is not a “process” within the meaning of § 101, and a
“thing occurring in nature under controlled propagation is not a manufacture.” Id. at 1393. The board agreed with
the examiner and entered new rejections under 35 U.S.C. § 103 (Non-obvious subject matter) and § 112 (specificity
in description). The court agreed with the rejection entered by the board under § 112, and therefore did not reach the
additional grounds of rejection). See also supra note 1.
64
Diamond v. Chakrabarty, 447 U.S. 303, 309 (1980).
65
See Ex parte Allen, 2 U.S.P.Q.2d (BNA) 1425 (Bd. Pat. App. & Interf. 1987) (relying on the U.S. Supreme
Court’s decision in Chakrabarty, the Board of Patent Appeals held that oysters, although they were animals,
qualified as patentable subject matter under § 101 of the Patent Act so long was they were made by man). See
generally Chakrabarty, 447 U.S. at 303.
66
35 U.S.C. § 101 (2000).
67
Chakrabarty, 447 U.S. at 308.
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composition of matter that is a product of human ingenuity and has a distinctive name, character,
and use is patentable subject matter under § 101 of the Act, even if it is living matter. 68 In
Chakrabarty, the Court found that a human-made, genetically engineered bacterium that was
capable of breaking down crude oil met the requirements necessary for a utility patent. 69 This
broad interpretation of the Act led to the USPTO issuing utility patents for plants, plant parts and
seeds. 70 The USPTO had issued nearly 2000 utility patents for plants by the time the U.S.
Supreme Court issued a clear ruling that plants were patentable subject matter under the general
Patent Act. 71
Because living matter was found to be patentable under the Patent Act of 1952, the Patent
Act’s patentable subject matter overlaps with the subject matter included under the purviews of
the PPA and the PVPA. However, the availability of one form of statutory protection does not
preclude the availability of protection under another form. 72 Examining the text of the Acts and
the legislative history, neither of the plant-specific Acts expressly excludes any plant subject
matter from protection under the general patent law. 73 The U.S. Supreme Court addressed the
differences in the Acts, but found that the differences did not present irreconcilable conflicts. 74
Thus, the different acts are to be read together.

68

Id. at 309-10.
Id. at 303 (“Respondent filed a patent application relating to his invention of a human-made, genetically
engineered bacterium capable of breaking down crude oil, a property which is possessed by no naturally occurring
bacteria. A patent examiner's rejection of the patent application's claims for the new bacteria was affirmed by the
Patent Office Board of Appeals on the ground that living things are not patentable subject matter under § 101. The
Court of Customs and Patent Appeals reversed, concluding that the fact that micro-organisms are alive is without
legal significance for purposes of the patent law. Held: A live, human-made micro-organism is patentable subject
matter under § 101. Respondent's micro-organism constitutes a ‘manufacture’ or ‘composition of matter’ within that
statute.”).
70
See Ex parte Hibberd, 227 U.S.P.Q. (BNA) 443 (Bd. Pat. App. & Infer. 1985).
71
J.E.M. AG Supply, Inc. v. Pioneer Hi-bred Int’l, Inc., 534 U.S. 124, 127 (2001).
72
Id. at 132, 145.
73
Id. at 137-38 (referring to the Plant Patent Act); id. at 143-44 (referring to the Plant Variety Protection Act).
74
Id. at 134-37, 142.
69
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The first Patent Act in 1790 defined patentable subject matter as “any new and useful art,
machine, manufacture, or composition of matter, or any new or useful improvement thereof.” 75
In 1952, when the patent laws were recodified, Congress replaced the word “art” with “process”
to form the Patent Act of 1952. 76

“Process” was substituted due to its broader scope of

interpretation, denoting a process, art, or method.

77

The common requirements of novelty,

utility, and non-obviousness remained intact. 78 Similarly, the strict description requirements
remained. 79
Therefore, to obtain utility patent protection, a plant breeder must show that the plant he
has developed is new, useful, and non-obvious.80 A plant is considered new if it was not known
or used by others before its discovery. 81 Moreover, to be new, the plant must be “one that
literally had not existed before, rather than one that had existed in nature but was newly found.” 82
To receive a utility patent, the invention must also be useful. 83 The “product of a patented
process is useful if it may serve some identifiable purpose.” 84 The invention’s potential for
commercial success is irrelevant; the standard is actual and identifiable usefulness.

85

Next, a

plant must be non-obvious. 86 The “emphasis on nonobviousness is one of inquiry, not quality.” 87

75

Act of Apr. 10, 1790, ch. 7, § 1, 1 Stat. 109, 109-10.
Ch. 10, § 101, 66 Stat. 792, 797 (1952).
77
See S. REP. NO. 1979-82, at 2409-10 (1952); see also 35 U.S.C. § 101(b) (2000) (“The term “process” means
process, art or method, and includes a new use of a known process, machine, manufacture, composition of matter, or
material”).
78
35 U.S.C. §§ 101-103 (2000).
79
Id. § 112.
80
Id. § 101.
81
See id. § 102(a).
82
Yoder Bros., Inc. v. Cal.-Fla. Plant Corp., 537 F.2d 1347, 1378 (5th Cir. 1976).
83
35 U.S.C. § 101 (2000).
84
Imperial Chem. Indus., PLC v. Henkel Corp., 545 F. Supp. 635, 645 (D. Del. 1982).
85
Id. at 644-45.
86
35 U.S.C. § 101 (2000).
87
Graham v. John Deere Co., 383 U.S. 1, 17 (1966).
76
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Obviousness serves as “Congress’ articulation of the constitutional standards of invention.” 88
Basically, there must be an actual invention, and non-obviousness requires the invention to entail
a degree of skill and ingenuity greater than that possessed by one with an ordinary level of
knowledge in the practice or trade. 89
In addition, the applicant for a utility patent must meet the stringent description
specifications of § 112 of the general patent law. 90 An applicant is required to provide “a written
description of the invention, and of the manner and process of making and using it, in such full,
clear, concise, and exact terms as to enable any person skilled in the art to which it pertains… to
make and use the same.” 91 Today, advances in biological knowledge and expertise in genetic
modifications have allowed plant breeders to satisfy these demanding description requirements.
In addition to a written description of the patented subject, an applicant must deposit “biological
material,” generally the seed of the plant, which is publicly accessible. 92
Due to the stringent requirements under general patent law, it is much more difficult to
obtain a utility patent for a plant than to obtain a Plant Patent or a PVPA certificate. However, if
an applicant can overcome these stringent requirements, a utility patent may be more desirable
due to its greater scope of protection. For example, unlike the PVPA, the Patent Act does not
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Yoder, 537 F.2d at 1378.
Id. at 1379.
90
35 U.S.C. § 112 (2000).
91
Id.
92
See 37 C.F.R. § 1.801-1.809 (2001). Section 1.801 states: “[B]iological material shall include material that is
capable of self- replication either directly or indirectly.” Section 1.802(a) provides: “Where an invention is, or relies
on, a biological material, the disclosure may include reference to a deposit of such biological material.” Section
1.802(b) provides:
Biological material need not be deposited unless access to such material is necessary for the satisfaction of
the statutory requirements for patentability under 35 U.S.C. 112. If a deposit is necessary, it shall be
acceptable if made in accordance with these regulations. Once deposited in a depository complying with
these regulations, a biological material will be considered to be readily available even though some
requirement of law or regulation of the United States or of the country in which the depository institution is
located permits access to the material only under conditions imposed for safety, public health or similar
reasons.
89
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contain exemptions that limit the scope of protection.93 Also, the PVPA limits protection to a
single variety 94 and the PPA limits protection to a specific plant 95 . The Patent Act has neither of
these limitations. Specifically, the PVPA protection falls short of a utility patent because a
breeder can use a plant that is protected by a PVP certificate to “develop” a new inbred line, but
the breeder cannot use a plant patented under the general Patent Act for such purpose. 96 With
greater protection under the Patent Act, a patentee may better serve his economic and/or
commercial interests.
A patent issued under the general Patent Act is good for twenty years and conveys the
“right to exclude others from making, using, offering for sale, or selling the invention throughout
the United States or importing the invention into the United States, and, if the invention is a
process to exclude others from using, offering for sale, or selling throughout the United States, or
importing into the United States, products made by that process.” 97
IV.

Conclusion

Though it was once held that living matter could not benefit from protection under
intellectual property laws in the United States, today there are alternative forms of statutory
protection to consider when dealing with living subject matter, including the Plant Patent Act,
the Plant Variety Protection Act, and the Patent Act of 1952. While considering the alternative
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The PVPA contains three exemptions from infringement limiting its scope in protection: 1. Public Interest
Exemption, § 2404; 2. Research Exemption, § 2544; and the Farmer’s Exemption, § 2543.
94
7 U.S.C. § 2402(a) (2000).
95
35 U.S.C. § 161 (2000). The PPA limits protection to a specific plant because of the asexual reproduction
requirement for a plant patent. Without sexual reproduction, all offspring is genetically identical to the original
plant. Thus, what is covered by a plant patent is any plant with a specific genetic identity covered by the patent,
whereas PVPA certificates protect seeds and offspring of certain plants not because of their genetic identity but
merely because of their status as offspring of a protected plant variety. See Imazio Nursery, Inc. v. Dania
Greenhouses, 69 F.3d 1560 (Fed. Cir. 1995), cert. denied, 518 U.S. 1018 (1996).
96
See 7 U.S.C. § 2541(a)(4) (2000) (stating that infringement includes “use of the variety in producing (as
distinguished form developing) a hybrid or different variety therefrom”).
97
35 U.S.C. § 154 (2000).
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forms of patent protection, one must be aware of the differences in the requirements and the
scope of protection offered by each Act. Many plant patent applicants may prefer to secure
patent protection under the general Patent Act due to its broad scope and greater protection.
However, plant varieties that are unable to satisfy the stringent requirements of the Patent Act
may qualify for protections afforded by the PPA or PVPA.
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